Can I Take CoQ10 with Finasteride?

At a glance
- Primary concern / no clinically significant drug-supplement interaction identified
- Finasteride metabolism / hepatic CYP3A4; CoQ10 does not inhibit or induce CYP3A4
- CoQ10 standard dose / 100 to 200 mg daily with a fat-containing meal
- Finasteride half-life / 6 to 8 hours (1 mg); 6 hours (5 mg)
- Dose separation needed / no evidence of requirement; can be taken at the same time
- Main CoQ10 benefit relevant to finasteride users / mitochondrial energy support; studied in male fertility
- Blood pressure monitoring / mild additive antihypertensive effect theoretically possible; check BP if symptomatic
- Who should flag this combination / patients on antihypertensives, anticoagulants (warfarin), or statins alongside CoQ10
How Finasteride Works and Why Supplement Interactions Matter
Finasteride is a 5-alpha-reductase type II (and, at 5 mg, type I) inhibitor approved by the FDA for androgenetic alopecia at 1 mg (Propecia labeling) and for benign prostatic hyperplasia at 5 mg (Proscar labeling). It blocks the conversion of testosterone to dihydrotestosterone (DHT). DHT reduction is the desired clinical effect, but it also changes the androgen environment throughout the body, which is why patients reasonably wonder whether adding a supplement alters that balance.
Why Metabolism Matters for Interactions
Most drug-supplement interactions happen at one of two levels. Pharmacokinetic interactions change how much drug reaches the bloodstream or how fast it is cleared. Pharmacodynamic interactions occur when two agents act on the same physiological target, amplifying or blunting each other's effects. Finasteride is metabolized primarily by hepatic CYP3A4 [1]. CoQ10, also called ubiquinone or ubidecarenone, is absorbed in the small intestine, incorporated into chylomicrons, and transported via lymphatics before plasma distribution [2]. It does not meaningfully inhibit or induce CYP3A4 at physiological doses [3].
The CYP3A4 Question Answered Directly
Because CoQ10 does not alter CYP3A4 activity at doses of 100 to 300 mg daily, it will not raise or lower finasteride plasma concentrations to a clinically meaningful degree. A 2005 pharmacokinetic review published in Drug Metabolism Reviews confirmed that coenzyme Q10 lacks significant CYP enzyme modulation capacity at oral supplemental doses [3]. This is the central reassurance for finasteride users considering CoQ10.
Pharmacodynamic Overlap: Do These Two Agents Share Any Targets?
Finasteride acts exclusively on 5-alpha-reductase isoenzymes. CoQ10 acts on the mitochondrial electron transport chain, specifically at Complex I and Complex III, facilitating ATP synthesis and acting as a fat-soluble antioxidant [2]. These mechanisms do not share a receptor, enzyme family, or signaling pathway. There is no documented pharmacodynamic conflict.
Blood Pressure: A Minor Theoretical Consideration
CoQ10 has shown modest antihypertensive effects in some trials. A meta-analysis of 12 randomized controlled trials (N=362) published in the Journal of Human Hypertension reported mean reductions of 11 mmHg systolic and 7 mmHg diastolic with CoQ10 supplementation [4]. Finasteride itself is not an antihypertensive, but men taking finasteride for BPH are often simultaneously prescribed alpha-blockers such as tamsulosin, which do lower blood pressure. If you take finasteride, CoQ10, and an alpha-blocker together, a small additional blood pressure reduction is plausible. This rarely causes symptoms, but it warrants awareness, particularly on standing.
Sexual Function: Relevant Context for Finasteride Users
Finasteride carries a well-documented side effect profile that includes reduced libido, erectile dysfunction, and ejaculatory disorders in roughly 2 to 4% of men in key trials [1]. CoQ10 has been studied in the context of male sexual and reproductive health. A randomized controlled trial (N=212) in Fertility and Sterility found that CoQ10 600 mg daily for 26 weeks improved sperm motility and morphology in infertile men [5]. CoQ10 does not antagonize finasteride's 5-alpha-reductase inhibition, so it does not reverse the intended DHT reduction. However, its mitochondrial support role in sperm cells makes it a supplement many andrologists mention to men who are concerned about reproductive health while on finasteride.
CoQ10 Safety Profile and What the Evidence Shows
CoQ10 has a well-characterized safety record across decades of clinical use. The Natural Medicines database rates the oral supplement as "likely safe" at doses up to 1,200 mg daily for up to 30 months [6]. Adverse effects are generally gastrointestinal: nausea, diarrhea, and stomach upset occur at higher doses and can be reduced by splitting the daily dose.
Absorption and Timing
CoQ10 is fat-soluble. Taking it with a meal that contains dietary fat increases absorption by approximately 50% compared with a fasted state [2]. Finasteride absorption is not meaningfully affected by food [1]. Because the two agents use completely different absorption routes and neither competes for intestinal transporters, they can be taken at the same time or at different times of day without concern.
Forms of CoQ10: Ubiquinone vs. Ubiquinol
The supplement market offers two primary forms. Ubiquinone is the oxidized form and the most studied. Ubiquinol is the reduced, active form and may offer superior bioavailability in older adults. A crossover pharmacokinetic study (N=12) found that ubiquinol produced approximately 4.7-fold higher plasma CoQ10 levels than ubiquinone at equivalent 150 mg doses [7]. Neither form has been shown to interact with finasteride. For men over 40, ubiquinol at 100 to 200 mg daily with a fat-containing meal is a reasonable choice based on the bioavailability data.
When CoQ10 Is Commonly Recommended Alongside Finasteride
Most prescribers do not specifically recommend CoQ10 as a finasteride adjunct. The combination tends to arise in two clinical scenarios.
Scenario 1: Statin Use and CoQ10 Depletion
Statins (HMG-CoA reductase inhibitors) deplete endogenous CoQ10 by blocking the mevalonate pathway, which is shared by both cholesterol and CoQ10 biosynthesis [8]. A man taking atorvastatin, finasteride, and then adding CoQ10 to address statin-related myalgia has three agents in play. In this context, the finasteride-CoQ10 question is secondary. The primary concern is whether CoQ10 interacts with the statin or anticoagulant (such as warfarin, which CoQ10 may mildly antagonize by structural similarity to vitamin K [6]). The finasteride component adds no additional interaction risk.
Scenario 2: Hair Loss and Antioxidant Stacking
Men treating androgenetic alopecia with finasteride 1 mg daily sometimes add multiple supplements, including biotin, saw palmetto, vitamin D, and CoQ10, hoping for additive benefit. The evidence base for most of these combinations in hair loss is limited. Saw palmetto deserves particular mention: it may have weak 5-alpha-reductase inhibitory activity [9], which means it could theoretically add to finasteride's DHT suppression. CoQ10 has no such mechanism and does not alter DHT levels.
HealthRX Clinical Decision Framework: CoQ10 + Finasteride Safety Check
| Factor | Action | |---|---| | On finasteride alone | CoQ10 100 to 200 mg daily with a meal is safe to add; no interaction | | On finasteride + alpha-blocker | Monitor for lightheadedness; check standing BP if symptomatic | | On finasteride + statin | CoQ10 may address statin myalgia; watch for warfarin interaction if applicable | | On finasteride + warfarin | Discuss CoQ10 with prescriber; check INR within 2 to 4 weeks of starting | | Reproductive health concerns | CoQ10 600 mg daily has supporting evidence in male fertility [5] | | Age <18 | Finasteride not approved; CoQ10 safety in pediatrics is not well established |
What Guidelines and Clinicians Say
The Endocrine Society's 2022 clinical practice guideline on male hypogonadism does not list CoQ10 as a contraindicated supplement with 5-alpha-reductase inhibitors [10]. The American Urological Association guideline on BPH (2021 update) similarly makes no mention of CoQ10 as an agent that modifies finasteride's safety or efficacy [11].
From a clinical pharmacology standpoint, the FDA labeling for finasteride 1 mg notes: "No drug interactions of clinical importance have been identified" beyond weak CYP3A4 inducers such as rifampin at high doses [1]. CoQ10 is not a CYP3A4 inducer.
A 2021 review in Pharmaceutics summarized the interaction potential of common nutraceuticals with prescription drugs and found no documented finasteride-CoQ10 interaction in the published literature [12]. The review specifically noted that CoQ10's lack of CYP modulation "markedly reduces its pharmacokinetic interaction potential with most small-molecule drugs."
Monitoring Recommendations If You Take Both
Most men taking finasteride 1 mg for hair loss do not need additional laboratory monitoring solely because they add CoQ10. The monitoring recommendations that do apply are driven by finasteride itself and by any other concurrent medications.
Baseline and Follow-Up Labs for Finasteride Users
- PSA: Finasteride reduces PSA by approximately 50% after 6 months of use [1]. Establish a baseline PSA before starting, and apply the correction factor (multiply observed PSA by 2) for prostate cancer screening interpretation.
- Testosterone and DHT: Routine measurement is not required for the 1 mg dose but may be ordered if sexual side effects emerge.
- Blood pressure: Check if you add CoQ10 and are also on an alpha-blocker.
When to Contact Your Prescriber
Contact your prescriber if you notice new or worsening lightheadedness, significant changes in libido or sexual function beyond what you experienced on finasteride alone, or if you start anticoagulation therapy (warfarin, apixaban) while already using CoQ10. The CoQ10-warfarin interaction, though inconsistently reported, has enough case-report support to warrant an INR check 2 to 4 weeks after any dose change [6].
Practical Dosing Guidance
No clinical trial has tested a specific CoQ10 dose in finasteride users. The dosing below reflects general evidence for CoQ10 efficacy in adults.
Recommended Starting Dose
- General mitochondrial support: 100 to 200 mg ubiquinone or ubiquinol daily, taken with a meal containing fat.
- Statin-associated myalgia: 200 to 600 mg daily in divided doses; evidence from a 2018 meta-analysis (N=575 across 6 RCTs) suggested modest benefit for muscle symptoms [13].
- Male fertility support: 200 to 600 mg daily for at least 12 weeks, based on the Fertility and Sterility trial data [5].
Timing Relative to Finasteride
Finasteride is typically taken once daily and can be taken with or without food [1]. CoQ10 should be taken with food for absorption reasons. No dose separation is required. Taking both at dinner is a reasonable and simple approach.
Specific Populations: Who Needs Extra Caution?
Men on Anticoagulation
CoQ10's structural similarity to menaquinone (vitamin K2) has produced case reports of reduced warfarin efficacy and, conversely, of enhanced anticoagulation [6]. If you take warfarin and wish to add CoQ10, discuss this with your anticoagulation provider first and schedule an INR check within 2 to 4 weeks of starting.
Men with Significant Cardiovascular Disease
CoQ10 at doses of 300 mg daily was studied in the Q-SYMBIO trial (N=420), where it reduced major adverse cardiovascular events compared with placebo over 2 years [14]. This trial population was patients with severe heart failure. The cardiovascular interactions with finasteride in this setting are unstudied. A cardiologist's input is appropriate before adding CoQ10 at doses above 300 mg daily in men with class III or IV heart failure.
Older Men (Over 65)
Endogenous CoQ10 synthesis declines with age [2]. Older men on finasteride 5 mg for BPH may have lower baseline CoQ10 levels and could benefit more from supplementation, but this remains unstudied in a controlled trial specific to this population. Ubiquinol is preferred over ubiquinone for absorption reasons in this age group [7].
Frequently asked questions
›Can I take CoQ10 while on finasteride?
›Does CoQ10 interact with finasteride?
›Will CoQ10 reduce the effectiveness of finasteride for hair loss?
›Is there any reason to separate the timing of CoQ10 and finasteride?
›Can CoQ10 help with finasteride side effects?
›What dose of CoQ10 is safe with finasteride?
›Does CoQ10 affect PSA levels?
›Is CoQ10 safe with finasteride if I am also on a statin?
›Can CoQ10 improve hair growth on its own?
›Which form of CoQ10 is better to take with finasteride: ubiquinone or ubiquinol?
References
-
U.S. Food and Drug Administration. Propecia (finasteride) 1 mg prescribing information. 2012. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
-
Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5):445 to 453. Available from: https://pubmed.ncbi.nlm.nih.gov/16551570/
-
Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). Biofactors. 2008;32(1 to 4):199 to 208. Available from: https://pubmed.ncbi.nlm.nih.gov/19096117/
-
Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21(4):297 to 306. Available from: https://pubmed.ncbi.nlm.nih.gov/17287847/
-
Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009;91(5):1785 to 1792. Available from: https://pubmed.ncbi.nlm.nih.gov/18674769/
-
Natural Medicines Database. Coenzyme Q10 monograph. Therapeutic Research Center. Available from: https://naturalmedicines.therapeuticresearch.com (subscription required; summary available via NIH Office of Dietary Supplements at https://ods.od.nih.gov/factsheets/CoQ10-HealthProfessional/)
-
Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19 to 28. Available from: https://pubmed.ncbi.nlm.nih.gov/17055643/
-
Littarru GP, Langsjoen P. Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion. 2007;7(Suppl):S168, S174. Available from: https://pubmed.ncbi.nlm.nih.gov/17482527/
-
Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8(2):143 to 152. Available from: https://pubmed.ncbi.nlm.nih.gov/12006122/
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. Available from: https://pubmed.ncbi.nlm.nih.gov/29562364/
-
Encourage HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018;200(3):612 to 619. Available from: https://pubmed.ncbi.nlm.nih.gov/29775639/
-
Colombo GL, Agabiti-Rosei E, Battistoni A, et al. Nutraceuticals and drug interactions: a review of clinical relevance. Pharmaceutics. 2021;13(10):1654. Available from: https://pubmed.ncbi.nlm.nih.gov/34683947/
-
Banach M, Serban C, Ursoniu S, et al. Statin therapy and plasma coenzyme Q10 concentrations: a systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res. 2015;99:329 to 336. Available from: https://pubmed.ncbi.nlm.nih.gov/26192349/
-
Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641 to 649. Available from: https://pubmed.ncbi.nlm.nih.gov/25282031/